Research Article
Primary Carcinoma of the Fallopian Tube: A Review of a Single Institution Experience of 8 Cases
Table 2
Summary of women characteristics and treatment.
| | Parameters | % |
| | Age (mean and range) | 55.5 yrs. (range 40–68 years) | | Postmenopausal | 62.5% | | ECOG performance score | | | 0 | 50% | | 1 | 25.0% | | 2 | 12.5% | | 3 | 12.5% | | Histology on frozen section in the presumed early stage group | | | Serous | 50% | | Poorly differentiated carcinoma | 50% | | Final histopathology | | | Serous | 37.5% | | Poorly differentiated carcinoma | 50% | | Papillary carcinoma | 12.5% | | Histological grade | | | 1 | 0% | | 2 | 12.5% | | 3 | 87.5% | | FIGO stage | | | Early stage (IA/B/C/IIA and all grades 1, 2, 3) | 4/8 (50%) | | Advanced stage (IIB/III/IV and all grades 1, 2, 3) | 4/8 (50%) | | Surgical procedure | | | Staging laparotomy | 4/4 (early stage) 100% | | Optimal debulking surgery | 3/4 (advanced stage) 75% | | Suboptimal surgery | 1/4 (advanced stage) 25% | | Chemotherapy response | | | Single agent carboplatin was administered in early stage disease | 4/4 (100%) | | Paclitaxel and Carboplatin combination in advanced stage disease | 4/4 (100%) |
|
|
